Skip to content

Comparison of agonist versus modified natural cycle for endometrial preparation for FET cycle in patients with severe endometriosis.

Comparison of GnRH-Agonist + HRT and Modified Natural Cycle Protocols for Endometrial Preparation in Frozen Embryo Transfer, on the Pregnancy Outcome in Patients with Severe Endometriosis Undergoing IVF

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110731007165N5
Enrollment
42
Registered
2019-07-08
Start date
2019-03-21
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis related infertility. Female infertility

Interventions

Intervention 1: Intervention group 1: The group I will undergo the short-term GnRH agonist protocol with hormone replacement therapy (HRT). From the 5th day of the mens, they will receive one oral con

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Aged between 20 to 38 years old Body sass index (BMI) greater than 30

Exclusion criteria

Exclusion criteria: Recurrent IVF failure (more than 2 times) Sever male factor infertility Grade I or II of Endometriosis Endocrine diseases Use of hormonal agents

Design outcomes

Primary

MeasureTime frame
Ongoing Pregnancy (after 10 Weeks of gestation). Timepoint: 10 weeks of gestation. Method of measurement: Diagnosis of obstetrician.

Secondary

MeasureTime frame
Implantation Rate. Timepoint: 2 Weeks after Positive BHCG Test. Method of measurement: Gestational Sac in ultrasound assessments.;Abortion Rate. Timepoint: At the end of the study. Method of measurement: Diagnosis of obstetrician.;Clinical Pregnancy Rate. Timepoint: Positive fetal heart beat 2 weeks after positive BHCG Test. Method of measurement: Ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Golparvar

Arash Women 's Hospital

dr.maryam.gol@gmail.com+98 21 7771 9922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026